{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T06:58:22Z","timestamp":1769842702730,"version":"3.49.0"},"reference-count":28,"publisher":"e-Century Publishing Corporation","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/ymob9811","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T06:15:14Z","timestamp":1753942514000},"page":"5502-5510","source":"Crossref","is-referenced-by-count":1,"title":["Mosapride combined with rebamipide demonstrates superior efficacy for treatment of chronic atrophic gastritis"],"prefix":"10.62347","volume":"17","author":[{"given":"Sisi","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/diseases10030035","article-title":"Inflammation and gastric cancer","volume":"10","author":"Jaroenlapnopparat","year":"2022","unstructured":"Jaroenlapnopparat A, Bhatia K and Coban S. Inflammation and gastric cancer. Diseases 2022; 10: 35.","journal-title":"Diseases"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12876-023-02662-1","article-title":"Chronic atrophic gastritis in different ages in South China: a 10-year retrospective analysis","volume":"23","author":"Zhang","year":"2023","unstructured":"Zhang Z and Zhang X. Chronic atrophic gastritis in different ages in South China: a 10-year retrospective analysis. BMC Gastroenterol 2023; 23: 37.","journal-title":"BMC Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.21037\/apm-21-1464","article-title":"Prevalence of chronic atrophic gastritis worldwide from 2010 to 2020: an updated systematic review and meta-analysis","volume":"11","author":"Yin","year":"2022","unstructured":"Yin Y, Liang H, Wei N and Zheng Z. Prevalence of chronic atrophic gastritis worldwide from 2010 to 2020: an updated systematic review and meta-analysis. Ann Palliat Med 2022; 11: 3697-3703.","journal-title":"Ann Palliat Med"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Li P, Zhu W, Ding J and Lei F. Study of Helicobacter pylori infection in patients with chronic atrophic gastritis and its relationship with lifestyle habits and dietary nutrient intake: a retrospective analysis. Medicine (Baltimore) 2024; 103: e36518.","DOI":"10.1097\/MD.0000000000036518"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.4251\/wjgo.v16.i10.4080","article-title":"Update understanding on diagnosis and histopathological examination of atrophic gastritis: a review","volume":"16","author":"XZ","year":"2024","unstructured":"Ma XZ, Zhou N, Luo X, Guo SQ and Mai P. Update understanding on diagnosis and histopathological examination of atrophic gastritis: a review. World J Gastrointest Oncol 2024; 16: 4080-4091.","journal-title":"World J Gastrointest Oncol"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Wang L, Ding X, Li P, Zhang F, Ru S, Wang F and Li L. Efficacy and safety of Weifuchun tablet for chronic atrophic gastritis: a systematic review and meta-analysis. PLoS One 2023; 18: e0284411.","DOI":"10.1371\/journal.pone.0284411"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"6705","DOI":"10.1007\/s00210-024-03047-1","article-title":"Mosapride stimulates human 5-HT(4)-serotonin receptors in the heart","volume":"397","author":"Neumann","year":"2024","unstructured":"Neumann J, Hesse C, Hofmann B and Gergs U. Mosapride stimulates human 5-HT(4)-serotonin receptors in the heart. Naunyn Schmiedebergs Arch Pharmacol 2024; 397: 6705-6720.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1186\/s12876-023-03014-9","article-title":"Prokinetics for the treatment of functional dyspepsia: an updated systematic review and network meta-analysis","volume":"23","author":"Qi","year":"2023","unstructured":"Qi Q, Wang N, Liu H and Li Y. Prokinetics for the treatment of functional dyspepsia: an updated systematic review and network meta-analysis. BMC Gastroenterol 2023; 23: 370.","journal-title":"BMC Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00535-009-0173-0","article-title":"The prokinetic effect of mosapride citrate combined with omeprazole therapy improves clinical symptoms and gastric emptying in PPI-resistant NERD patients with delayed gastric emptying","volume":"45","author":"Futagami","year":"2010","unstructured":"Futagami S, Iwakiri K, Shindo T, Kawagoe T, Horie A, Shimpuku M, Tanaka Y, Kawami N, Gudis K and Sakamoto C. The prokinetic effect of mosapride citrate combined with omeprazole therapy improves clinical symptoms and gastric emptying in PPI-resistant NERD patients with delayed gastric emptying. J Gastroenterol 2010; 45: 413-421.","journal-title":"J Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.3390\/jcm11071965","article-title":"Randomized controlled trial comparing the efficacy of sustained-release formula of mosapride-plus-esomeprazole combination therapy to esomeprazole monotherapy in patients with gastroesophageal reflux disease","volume":"11","author":"Jeon","year":"2022","unstructured":"Jeon HK, Kim GH, Lee MW, Joo DC and Lee BE. Randomized controlled trial comparing the efficacy of sustained-release formula of mosapride-plus-esomeprazole combination therapy to esomeprazole monotherapy in patients with gastroesophageal reflux disease. J Clin Med 2022; 11: 1965.","journal-title":"J Clin Med"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Zvyaglova MY, Knyazev OV and Parfenov AI. Pharmacological and clinical feature of rebamipide: new therapeutic targets. Ter Arkh 2020; 92: 104-111.","DOI":"10.26442\/00403660.2020.02.000569"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1007\/s10620-021-07038-7","article-title":"Rebamipide for the improvement of gastric atrophy and intestinal metaplasia: a prospective, randomized, pilot study","volume":"67","author":"Lee","year":"2022","unstructured":"Lee JS, Jeon SW, Lee HS, Kwon YH, Nam SY, Bae HI and Seo AN. Rebamipide for the improvement of gastric atrophy and intestinal metaplasia: a prospective, randomized, pilot study. Dig Dis Sci 2022; 67: 2395-2402.","journal-title":"Dig Dis Sci"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Hou D, Yang M, Hu Z and Yang L. Effects of rebamipide for chronic atrophic gastritis: a protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020; 99: e20620.","DOI":"10.1097\/MD.0000000000020620"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.gastrohep.2023.09.001","article-title":"History and clinical guidelines for chronic atrophic gastritis and the assessment of gastric cancer risk","volume":"46","author":"Delgado-Guillena","year":"2023","unstructured":"Delgado-Guillena P, Velamazan-Sandalinas R, Jimenez Sanchez J, Fuentes-Valenzuela E, Garcia-Morales N, Cuatrecasas M, Jimeno M, Moreira L and Albeniz E. History and clinical guidelines for chronic atrophic gastritis and the assessment of gastric cancer risk. Gastroenterol Hepatol 2023; 46: 727-731.","journal-title":"Gastroenterol Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"942091","DOI":"10.3389\/fonc.2022.942091","article-title":"Risk of progression in patients with chronic atrophic gastritis: a retrospective study","volume":"12","author":"Sun","year":"2022","unstructured":"Sun L, Jin X, Huang L, Zhao J, Jin H, Chen M, Zhang C and Lu B. Risk of progression in patients with chronic atrophic gastritis: a retrospective study. Front Oncol 2022; 12: 942091.","journal-title":"Front Oncol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s12967-023-04736-w","article-title":"Chronic atrophic gastritis and risk of incident upper gastrointestinal cancers: a systematic review and meta-analysis","volume":"22","author":"Li","year":"2024","unstructured":"Li J, Pan J, Xiao D, Shen N, Wang R, Miao H, Pu P, Zhang H, Yv X and Xing L. Chronic atrophic gastritis and risk of incident upper gastrointestinal cancers: a systematic review and meta-analysis. J Transl Med 2024; 22: 429.","journal-title":"J Transl Med"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Yu Y, Yang X, Hu G, Yin S, Zhang F, Wen Y, Zhu Y and Liu Z. Clinical efficacy of moluodan in the treatment of chronic atrophic gastritis: a protocol for systematic review and meta-analysis. Medicine (Baltimore) 2022; 101: e32303.","DOI":"10.1097\/MD.0000000000032303"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"7030","DOI":"10.1038\/s41598-024-57870-w","article-title":"A randomized controlled study to assess the effect of mosapride citrate on intestinal recovery following gastrectomy","volume":"14","author":"Jun","year":"2024","unstructured":"Jun S, Oh S, Jung JE, Kwon IG and Noh SH. A randomized controlled study to assess the effect of mosapride citrate on intestinal recovery following gastrectomy. Sci Rep 2024; 14: 7030.","journal-title":"Sci Rep"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/01.mcg.0000210103.82241.97","article-title":"The effect of mosapride on esophageal motility and bolus transit in asymptomatic volunteers","volume":"40","author":"Cho","year":"2006","unstructured":"Cho YK, Choi MG, Han HW, Park JM, Oh JH, Jeong JJ, Cho YS, Lee IS, Kim SW, Choi KY and Chung IS. The effect of mosapride on esophageal motility and bolus transit in asymptomatic volunteers. J Clin Gastroenterol 2006; 40: 286-292.","journal-title":"J Clin Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.5009\/gnl230372","article-title":"Rebamipide prevents the hemoglobin drop related to mucosal-damaging agents at a level comparable to proton pump inhibitors","volume":"18","author":"Kim","year":"2024","unstructured":"Kim JE, Lee YC, Kim TS, Kim ER, Hong SN, Kim YH, Kim K and Chang DK. Rebamipide prevents the hemoglobin drop related to mucosal-damaging agents at a level comparable to proton pump inhibitors. Gut Liver 2024; 18: 1026-1036.","journal-title":"Gut Liver"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"5152","DOI":"10.3748\/wjg.v30.i48.5152","article-title":"Efficacy and safety of rebamipide\/nizatidine in patients with erosive gastritis: a randomized, multicenter, phase 4 study","volume":"30","author":"Kang","year":"2024","unstructured":"Kang D, Choi MG, Shim KN, Jung HK, Nam SJ, Park JH, Kim SG, Kim NH, Hong SJ, Jeon TJ, Chung JI, Lee HL, Lee JY, Kim TO, Lee CM, Kim SM, Kim JH, Kim JE, Moon JS, Kim HD, Lee WS and Park HJ. Efficacy and safety of rebamipide\/nizatidine in patients with erosive gastritis: a randomized, multicenter, phase 4 study. World J Gastroenterol 2024; 30: 5152-5161.","journal-title":"World J Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.2169\/internalmedicine.53.2160","article-title":"Efficacy and safety of proton pump inhibitors (PPIs) plus rebamipide for endoscopic submucosal dissection-induced ulcers: a meta-analysis","volume":"53","author":"Wang","year":"2014","unstructured":"Wang J, Guo X, Ye C, Yu S, Zhang J, Song J, Cao Z, Wang J, Liu M and Dong W. Efficacy and safety of proton pump inhibitors (PPIs) plus rebamipide for endoscopic submucosal dissection-induced ulcers: a meta-analysis. Intern Med 2014; 53: 1243-1248.","journal-title":"Intern Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s40261-015-0329-z","article-title":"Effect of rebamipide on the premalignant progression of chronic gastritis: a randomized controlled study","volume":"35","author":"Han","year":"2015","unstructured":"Han X, Jiang K, Wang B, Zhou L, Chen X and Li S. Effect of rebamipide on the premalignant progression of chronic gastritis: a randomized controlled study. Clin Drug Investig 2015; 35: 665-673.","journal-title":"Clin Drug Investig"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1080\/gas.37.7.785.791","article-title":"Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study","volume":"37","author":"Sipponen","year":"2002","unstructured":"Sipponen P, Ranta P, Helske T, Kaariainen I, Maki T, Linnala A, Suovaniemi O, Alanko A and Harkonen M. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study. Scand J Gastroenterol 2002; 37: 785-791.","journal-title":"Scand J Gastroenterol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"112542","DOI":"10.1016\/j.biopha.2021.112542","article-title":"Traditional Chinese medicine for precancerous lesions of gastric cancer: a review","volume":"146","author":"Xu","year":"2022","unstructured":"Xu W, Li B, Xu M, Yang T and Hao X. Traditional Chinese medicine for precancerous lesions of gastric cancer: a review. Biomed Pharmacother 2022; 146: 112542.","journal-title":"Biomed Pharmacother"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41522-024-00623-4","article-title":"The dynamic oral-gastric microbial axis connects oral and gastric health: current evidence and disputes","volume":"11","author":"Xia","year":"2025","unstructured":"Xia M, Lei L, Zhao L, Xu W, Zhang H, Li M, Hu J, Cheng R and Hu T. The dynamic oral-gastric microbial axis connects oral and gastric health: current evidence and disputes. NPJ Biofilms Microbiomes 2025; 11: 1.","journal-title":"NPJ Biofilms Microbiomes"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2642551","DOI":"10.1155\/2022\/2642551","article-title":"Bile reflux gastritis: insights into pathogenesis, relevant factors, carcinomatous risk, diagnosis, and management","volume":"2022","author":"Shi","year":"2022","unstructured":"Shi X, Chen Z, Yang Y and Yan S. Bile reflux gastritis: insights into pathogenesis, relevant factors, carcinomatous risk, diagnosis, and management. Gastroenterol Res Pract 2022; 2022: 2642551.","journal-title":"Gastroenterol Res Pract"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"115868","DOI":"10.1016\/j.biopha.2023.115868","article-title":"Licorice flavonoid alleviates gastric ulcers by producing changes in gut microbiota and promoting mucus cell regeneration","volume":"169","author":"Wu","year":"2023","unstructured":"Wu Y, Guo Y, Huang T, Huang D, Liu L, Shen C, Jiang C, Wang Z, Chen H, Liang P, Hu Y, Zheng Z, Liang T, Zhai D, Zhu H and Liu Q. Licorice flavonoid alleviates gastric ulcers by producing changes in gut microbiota and promoting mucus cell regeneration. Biomed Pharmacother 2023; 169: 115868.","journal-title":"Biomed Pharmacother"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/7\/ajtr0163918.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:52:01Z","timestamp":1766022721000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/7\/ajtr0163918.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":28,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/ymob9811","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}